Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease

Type 2 diabetes (T2D) and metabolic (dysfunction)-associated steatotic liver disease (MASLD) affect a growing number of individuals worldwide. T2D and MASLD often coexist and substantially elevate the risk of adverse hepatic and cardiovascular clinical outcomes. Several common pathogenetic mechanism...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Daniela Ciobârcă, Adriana Florinela Cătoi, Laura Gavrilaș, Roxana Banc, Doina Miere, Lorena Filip
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2025-02-01
Saila:	Pharmaceuticals
Gaiak:	type 2 diabetes metabolic (dysfunction)-associated steatotic liver disease non-alcoholic fatty liver disease gut dysbiosis natural bioactive compounds berberine
Sarrera elektronikoa:	https://www.mdpi.com/1424-8247/18/2/279
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!